Literature DB >> 8929179

Seven-year follow-up of neurologic involvement in Behçet syndrome.

G Akman-Demir1, B Baykan-Kurt, P Serdaroglu, H Gürvit, S Yurdakul, H Yazici, S Bahar, E Aktin.   

Abstract

OBJECTIVE: To determine the long-term prognosis of neurologic involvement in Behçet syndrome.
DESIGN: Forty-six patients with Behçet syndrome, who had been the subjects of a previous report with short-term follow-up, were reexamined 7 years later; 42 of them could be reexamined neurologically. Neuropsychological testing, magnetic resonance imaging, electromyography, and evoked potential studies were performed when available.
RESULTS: Of the 27 patients who had had headaches without any neurologic symptoms or signs previously, 2 had developed an acute neurologic attack. In addition, 7 patients in this group showed minor abnormalities on neurologic examination and/or other laboratory investigations, without history of any attacks. Among the previous neuro-Behçet group (n = 15), as defined by the presence of neurologic signs or symptoms, other than headache, 7 had a stationary course, while 8 had been progressive. Three of the latter group had died. Patients with progressive course had had abnormal cerebrospinal fluid findings at the time of the previous report, whereas patients with a stationary course had not.
CONCLUSIONS: Silent neurologic involvement may occur in Behçet syndrome. Patients should undergo periodic neurologic evaluation. The long-term prognosis in neuro-Behçet syndrome does not seem to be as favorable as we observed in short-term follow-up. Cerebrospinal fluid findings may predict prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8929179     DOI: 10.1001/archneur.1996.00550070133022

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

Review 1.  Standard and novel therapeutic approaches to Behçet's disease.

Authors:  Ahmet Gul
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Autonomic neural control of the cardiovascular system in patients with Behçet's disease in the absence of neurological involvement.

Authors:  Tansel Erol; Abdullah Tekin; Müge Tufan; Hakan Altay; Göknur Tekin; Muhammet Bilgi; Bülent Özin; Eftal Yücel; Haldun Müderrisoğlu
Journal:  Clin Rheumatol       Date:  2012-07-25       Impact factor: 2.980

3.  Promoter -2518 single nucleotide polymorphism of monocyte chemoattractant protein-1 is associated with clinical severity in Behçet's disease.

Authors:  Seong-Kyu Kim; Won-Cheoul Jang; Young-Chang Ahn; Sang-Hyun Lee; Shin-Seok Lee; Jin-Wuk Hur
Journal:  Inflamm Res       Date:  2012-04-03       Impact factor: 4.575

Review 4.  Cerebral venous thrombosis in Behçet's disease: a systematic review.

Authors:  D Aguiar de Sousa; T Mestre; J M Ferro
Journal:  J Neurol       Date:  2011-01-06       Impact factor: 4.849

5.  Cranial MRI in Behçet's disease: 134 examinations of 98 patients.

Authors:  G Akman-Demir; S Bahar; O Coban; B Tasci; P Serdaroglu
Journal:  Neuroradiology       Date:  2003-10-14       Impact factor: 2.804

6.  Rapid, complete and sustained response to corticosteroids and pulse cyclophosphamide therapy in a patient with behçet and central nervous disease.

Authors:  Concepción M Nuñez-Sotelo; Luis A Gutiérrez-Gonzalez; Martín A Rodriguez
Journal:  Maedica (Buchar)       Date:  2012-12

7.  Heart-rate recovery index is impaired in Behçet's disease.

Authors:  Ergun Baris Kaya; Hikmet Yorgun; Ali Akdogan; Ahmet Hakan Ates; Ugur Canpolat; Hamza Sunman; Kudret Aytemir; Lale Tokgozoglu; Giray Kabakci; Meral Calguneri; Hilmi Ozkutlu; Ali Oto
Journal:  Tex Heart Inst J       Date:  2009

Review 8.  Differential diagnosis and management of Behçet syndrome.

Authors:  Nicola L Ambrose; Dorian O Haskard
Journal:  Nat Rev Rheumatol       Date:  2012-09-25       Impact factor: 20.543

9.  Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients.

Authors:  B Taşçi; H Direskeneli; P Serdaroglu; G Akman-Demir; M Eraksoy; G Saruhan-Direskeneli
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

Review 10.  Behçet's Disease and Nervous System Involvement.

Authors:  Murat Kürtüncü; Erdem Tüzün; Gulsen Akman-Demir
Journal:  Curr Treat Options Neurol       Date:  2016-05       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.